A number of investment brokers have recently updated their price targets on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

05/19/2015 – Bio-Reference Laboratories, Inc. was upgraded to “hold” by analysts at Zacks.

12/19/2014 – Bio-Reference Laboratories, Inc. had its “hold” rating reiterated by analysts at William Blair.

08/28/2014 – Bio-Reference Laboratories, Inc. was downgraded to “underperform” by analysts at Bank of America Merrill Lynch.

01/20/2014 – Bio-Reference Laboratories, Inc. was downgraded to “hold” by analysts at TheStreet.

11/27/2013 – Bio-Reference Laboratories, Inc. was downgraded to “neutral” by analysts at Sidoti.

The share price of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) was up +0.00% during the last day of trading, with a day high of 0.00. 0 shares were traded during the last session.

The stock’s 50 day moving average is 41.81 and its 200 day moving average is 36.97.Bio-Reference Laboratories, Inc. has a 52-week low of 26.32 and a 52-week high of 47.49.

View other investors thoughts on Bio-Reference Laboratories, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.